8th International Myotonic Dystrophy Consortium Meeting

第八届国际强直性肌营养不良联盟会议

• 批准号: 8248432
• 负责人: RICHARD T MOXLEY
• 金额: $ 3.3万
• 依托单位: UNIVERSITY OF ROCHESTER
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-09-30 至 2012-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8248432
• 关键词: 19q13.3; 3' Untranslated Regions; 3q21; Advocacy; Advocate; Anesthesiology; Animal Model; Basic Science; Brain; Cardiology; Cardiovascular system; Caregivers; Caring; Cell model; Clinical; Clinical Investigator; Clinical Research; Clinical Trials; Collaborations; Data; Development; Development Plans; Devices; Disease; Disease Management; Disease Progression; Distal; Endocrine system; Environment; European; Eye; Family Caregiver; Family member; Florida; Foundations; Functional disorder; Funding; Funding Agency; Future; Genes; Genetic; Germany; Goals; Grant; Growth; Industry; Interdisciplinary Study; International; Introns; Investigation; Lead; Letters; Mind; Modality; Molecular Biology; Mutation; Myotonia; Myotonic Disorders; Myotonic Dystrophy; Neurobiology; Neurology; Outcome Measure; Pathology; Patient Care; Patients; Peer Review; Pharmaceutical Preparations; Progress Reports; Provider; Proximal Myotonic Myopathy; Research; Research Infrastructure; Research Personnel; Schedule; Scientist; Senior Scientist; Smooth Muscle; Structure; Symptoms; Therapeutic; Translational Research; Work; abstracting; career; clinical care; early onset; efficacy testing; innovation; interest; lectures; medical specialties; meetings; multidisciplinary; novel strategies; patient advocacy group; patient oriented; posters; symposium; therapeutic development; wasting

DESCRIPTION (provided by applicant): This application proposes funding for the 8th meeting of the International Myotonic Dystrophy Consortium (IDMC-8). IDMC-8 is scheduled to convene in Clearwater, Florida from November 30th to December 3rd, 2011. IDMC-8 will bring together top scientists from around the world to discuss high-impact, interdisciplinary research on myotonic dystrophy (DM). The objective of the conference is to promote scientific discussion and facilitate interdisciplinary exchange. This meeting brings together leading basic researchers in the field with clinicians and clinical investigators representing a broad range of specialties including: neurology, cardiology, anesthesiology, clinical trials, neurobiology, pathology, genetics and molecular biology. Their interactions and discussions stimulate new approaches to research and clinical care and provide opportunities to develop and strengthen collaborative studies. Researchers and clinicians having special interest and expertise in DM will serve as co-chairs of the scientific sessions during the meeting. The first day of IDMC-8 will include: registration; a satellite symposium on outcome measures to assess disease progression in myotonic dystrophy; keynote lectures; and a welcoming reception. The subsequent three days of the meeting will be devoted to scientific sessions in which researchers and clinicians present peer-reviewed, selected abstracts on basic, clinical and translational research topics. The scientific sessions begin at 8:00 AM and conclude between 5:30 to 7:30 PM each day. There will be two formal poster sessions. Posters will be displayed during the entire meeting. All the sessions at IDMC-8 will focus on "cutting edge" topics and research, such as, disease mechanisms of myotonic dystrophy, animal and cell models, clinical aspects and management of disease symptoms, and therapeutic development. On the final day, there will be patient-oriented sessions to promote discussion among patients, care-givers, representatives of patient advocacy groups, clinicians, and investigators. These sessions will be in "lay" terms to encourage interaction and exchanges of ideas among patients and investigators. The final afternoon will begin with highlights from the previous sessions, followed by advocacy group presentations, and a session for questions from patients and family members. PUBLIC HEALTH RELEVANCE: This application proposes funding for the 8th meeting of the International Myotonic Dystrophy Consortium (IDMC-8). Its goal is to facilitate discussions between clinical and bench researchers, and interface them with scientists and clinicians of related fields, representatives of regulatory and grant funding agencies, patient advocacy groups, patients with myotonic dystrophies and their families and caregivers. The IDMC meeting is the only conference in the world that brings together such a diverse group of attendees, including the leading experts in the field dedicated to the study, treatment and cure of myotonic dystrophy.

描述（由申请人提供）：本申请建议为国际强直性肌营养不良症联盟（IDMC-8）第8次会议提供资金。IDMC-8定于2011年11月30日至12月3日在佛罗里达的克利尔沃特召开。IDMC-8将汇集来自世界各地的顶尖科学家，讨论强直性肌营养不良（DM）的高影响力，跨学科研究。会议的目的是促进科学讨论和促进跨学科交流。本次会议汇集了该领域领先的基础研究人员与代表广泛专业的临床医生和临床研究人员，包括：神经病学，心脏病学，麻醉学，临床试验，神经生物学，病理学，遗传学和分子生物学。他们的互动和讨论激发了研究和临床护理的新方法，并提供了发展和加强合作研究的机会。对糖尿病有特殊兴趣和专业知识的研究人员和临床医生将在会议期间担任科学会议的联合主席。IDMC-8的第一天将包括：注册;关于评估强直性肌营养不良疾病进展的结果措施的卫星研讨会;主题演讲;和欢迎招待会。会议随后的三天将专门用于科学会议，研究人员和临床医生将提交关于基础，临床和转化研究主题的同行评审，精选摘要。科学会议开始于上午8：00，每天下午5：30至7：30结束。将有两个正式的海报会议。整个会议期间将张贴海报。IDMC-8的所有会议都将集中在“前沿”主题和研究上，例如强直性肌营养不良的疾病机制、动物和细胞模型、疾病症状的临床方面和管理以及治疗开发。在最后一天，将有面向患者的会议，以促进患者，护理人员，患者倡导团体，临床医生和研究人员的代表之间的讨论。这些会议将以“非专业”的方式进行，以鼓励患者和研究者之间的互动和思想交流。最后一个下午将开始与亮点从以前的会议，其次是倡导小组介绍，并从病人和家属的问题会议。 公共卫生相关性：本申请为国际强直性肌营养不良症联盟（IDMC-8）第8次会议提供资金。它的目标是促进临床和实验室研究人员之间的讨论，并将他们与相关领域的科学家和临床医生，监管和赠款资助机构的代表，患者倡导团体，强直性肌营养不良患者及其家属和护理人员联系起来。IDMC会议是世界上唯一一个汇集了如此多元化的与会者群体的会议，其中包括致力于强直性肌营养不良研究、治疗和治愈的该领域的领先专家。